aMoon
aMoon is a leading Israeli life sciences venture fund. Our team is passionate about building successful businesses and helping Israeli biopharma, digital health and medical technology companies realize their potential.
Author:
gaby hirsch
Guardant buys MetaSight for $59M upfront to acquire blood test tech